✦ LIBER ✦

P-596 Chemotherapy treatments outcome and toxicities in the treatmentof elderly patients (age ⩾ 70) with lung cancer

✍ Scribed by Yau, T.; Ashley, S.; Popat, S.; Norton, A.; Matakidou, A.; O'Brien, M.

Book ID: 118573500
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 136 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)81089-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-536 Chemotherapy with gemcitabine and

P-536 Chemotherapy with gemcitabine and cisplatin in the treatment ofadvanced non-small cell lung cancer in elderly patients

✍ Miron, L.; Clement, D.; Marinca, M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Chemotherapy is Beneficial for Elderly P

Chemotherapy is Beneficial for Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Patients Aged 70-74, 75-79, and 80 or Older in Japan

✍ Tomoya Kawaguchi; Akihiro Tamiya; Atsuhisa Tamura; Masamichi Arao; Ryusei Saito; 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 444 KB

P.28 Tolerance of the treatment with che

P.28 Tolerance of the treatment with chemotherapy and/or radiotherapy in older patients with advanced lung cancer

✍ Pilnik, N.; Mareca, O.; Bielochercovsky, R.; Carri, D. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 73 KB

84P VALUE OF CURATIVE TREATMENT CHEMOTHE

84P VALUE OF CURATIVE TREATMENT CHEMOTHERAPY AND RADIOTHERAPY VERSUS PALLIATIVE RADIOTHERAPY ALONE IN THE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER

✍ Dzhugashvili, M.; Fondevilla, A.; Bregu, L.; Mata, F.; Puchades, V.; Ramos, D.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Exploring Non-lobectomy Options In Elder

Exploring Non-lobectomy Options In Elderly Patients (age >70 Yrs) With Early-stage Non-small Cell Lung Cancer: Comparison Of Stereotactic Radiation (SBRT) versus Sublobar Resection And Intraoperative Seed Implant (IOS)

✍ Desai, P.A.; Singh, P.; Wernicke, A.G.; Nori, D.; Chao, K.C.; Parashar, B. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase 2 trial of docetaxel and gefitinib

Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older

✍ George R. Simon; Martine Extermann; Alberto Chiappori; Charles C. Williams; Mube 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

## Abstract ## BACKGROUND This is a phase 2 study of chemotherapy‐naive patients, 70 years of age or older, with nonsmall‐cell lung cancer (NSCLC) who were treated with docetaxel and gefitinib. The primary endpoint was response rate (RR). Secondary endpoints were overall survival (OS) and progress